Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Agile Therapeutics Inc. AGRX

Alternate Symbol(s):  AGXRW

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.


Recent & Breaking News (NDAQ:AGRX)

Agile Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare Conference

GlobeNewswire February 14, 2017

AGRX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017

Business Wire February 13, 2017

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Agile Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline

PR Newswire February 10, 2017

March 7 Deadline Alert: Law Offices of Howard G. Smith Reminds Agile Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm

Business Wire February 9, 2017

AGRX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017

GlobeNewswire February 8, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agile Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – AGRX

GlobeNewswire February 3, 2017

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Agile Therapeutics, Inc. (AGRX) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

GlobeNewswire February 3, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Agile Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017 – AGRX

GlobeNewswire February 3, 2017

Agile Therapeutics to Present at the 2017 BIO CEO & Investor Conference

GlobeNewswire February 2, 2017

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire January 30, 2017

Lawsuit for Investors in Agile Therapeutics Inc (NASDAQ:AGRX) shares announced by Shareholders Foundation

GlobeNewswire January 30, 2017

RM LAW Announces Class Action Lawsuit Against Agile Therapeutics, Inc.

PR Newswire January 27, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agile Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AGRX

PR Newswire January 27, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. – AGRX

GlobeNewswire January 26, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017

GlobeNewswire January 26, 2017

WOLF HALDENSTEIN AGILE THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed on behalf of shareholders of Agile Therapeutics, Inc. in the District of New Jersey

GlobeNewswire January 25, 2017

How These Generic Drugs Stocks are Faring? -- Catalyst Pharma, Sophiris Bio, Momenta Pharma, and Agile Therapeutics

PR Newswire January 23, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Agile Therapeutics, Inc. and Certain Officers – AGRX

GlobeNewswire January 20, 2017

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Agile Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire January 20, 2017

Agile Therapeutics to Present at Noble Capital Markets’ Thirteenth Annual Investor/Equity Conference

GlobeNewswire January 19, 2017